ARTEEMAXX 200 contains artesunate, an artemisinin derivative with rapid antimalarial activity. After administration, artesunate is converted into the active metabolite dihydroartemisinin, which acts primarily against the erythrocytic stages of malaria parasites. This results in a rapid reduction in parasite levels in the bloodstream and helps relieve the manifestations of malaria.
The medication may be used:
Artesunate is a well-studied component of modern malaria treatment. Clinical studies and systematic reviews have demonstrated the high efficacy of artemisinin derivatives in rapidly reducing parasitemia. For malaria treatment, oral artesunate is generally used as part of combination therapy rather than as prolonged monotherapy, because combination treatment helps reduce the risk of persistent infection and antimalarial drug resistance.
The medication is used for the treatment of malaria, including infections caused by Plasmodium falciparum. Artesunate rapidly acts against the erythrocytic stages of malaria parasites, helping reduce parasitemia and relieve symptoms.
For uncomplicated malaria, oral artesunate is generally administered as part of combination therapy. The choice of combination, dosage, and treatment duration depends on the type of malaria, geographic region where the infection was acquired, age, body weight, and clinical condition of the patient.
The medication should be taken orally strictly according to the regimen prescribed by a healthcare professional. Tablets should be swallowed with water while maintaining the prescribed dosing intervals. For malaria treatment, artesunate is generally used in combination with another antimalarial medicine, with the specific regimen depending on the type of infection and current treatment recommendations. The dosage should not be changed and treatment should not be discontinued without medical advice.
Side Effects
